Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction
NCT ID: NCT03895580
Last Updated: 2022-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
267 participants
INTERVENTIONAL
2019-04-08
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
NCT00357955
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
NCT02842957
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
NCT00409240
Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes
NCT00508014
Fruit and Vegetable Prescription Program
NCT04072757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Both POP education strategies will be delivered within a supermarket-based retail clinic and will utilize the aisles and products of the supermarket. The interventions will be delivered by a registered dietitian nutritionist (RDN). The online portion of the combined online/in-store education POP strategy will include online grocery shopping, online recipe resources, a grocery pickup or home delivery service, and a phone application to better select healthy foods.
Both strategies will be offered in addition to a "standard of care" medical nutrition therapy session. The DASH dietary pattern has been empirically tested and shown to favorably modify blood pressure, blood cholesterol, insulin sensitivity, and weight status.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Medical nutrition therapy session with no further dietary counseling throughout the study.
No interventions assigned to this group
Group 2
Medical nutrition therapy session plus in-store point-of-purchase (POP) education.
In-store POP education
Six in-store nutrition counseling sessions with a registered dietitian nutritionist.
Group 3
Medical nutrition therapy session plus combined in-store/online point-of-purchase (POP) education.
In-store POP education
Six in-store nutrition counseling sessions with a registered dietitian nutritionist.
Online POP education
Education on the use of an online grocery shopping, an online recipe tool, a grocery pickup service, a home grocery delivery service, and a phone application that promotes healthy food selection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-store POP education
Six in-store nutrition counseling sessions with a registered dietitian nutritionist.
Online POP education
Education on the use of an online grocery shopping, an online recipe tool, a grocery pickup service, a home grocery delivery service, and a phone application that promotes healthy food selection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Speak, write, read English fluently
3. In-person outpatient visit with a UC Health primary care network (PCN) provider within the last 12 months
4. Major food planner of their household, which may include planning, purchasing, and/or preparing greater than 50% of the meals or foods consumed at home
5. Existing shopper at a study site Kroger (≥50% of grocery store food dollars spent at Kroger) with a Kroger Loyalty ID number
6. Willing to use a new individual Kroger Loyalty ID number for the duration of the study
7. Access to a home desktop or laptop computer with reliable internet access
8. Access to an email account that can be used for the duration of the study
9. Able to independently purchase and prepare food:
1. Reliable transportation to participating Kroger store
2. Ability to stand for significant periods of time to grocery shop and prepare food at home
3. Tools and equipment needed to prepare own food at home, such as a kitchen equipped with basic cooking tools (e.g. burner, pan, spatula, sink)
10. Presence of a cardiovascular risk factor(s) (at least one):
1. Hypertension (defined by one of the following):
* Blood pressure measurement: systolic blood pressure (SBP) 130-189 mm Hg and/or diastolic blood pressure (DBP) 80-109 mm Hg (at Visit #1)
* Current treatment with an oral medication prescribed by a physician for blood pressure lowering (defined by one of the following):
1. Beta blockers
2. Diuretics (e.g. thiazide or thiazide-like diuretics, loop diuretics, aldosterone antagonists, potassium-sparing diuretics)
3. Angiotensin-converting enzyme inhibitors
4. Angiotensin II receptor blockers
5. Direct renin inhibitors (i.e. aliskiren)
6. Calcium channel blockers (dihydropyridine and nondihydropyridine)
7. Calcium alpha2-agonist and other centrally acting drugs (e.g. clonidine)
8. Direct vasodilators (e.g. hydralazine)
2. Body-mass index (BMI) measurement ≥30 kg/m2 (at Visit #1)
3. Hypercholesterolemia (defined by one of the following):
* Low density lipoprotein cholesterol (LDL-C) 130-189 mg/dl (at Visit #1)
* Current treatment with a medication prescribed by a physician for hypercholesterolemia (defined by one of the following):
1. Statins
2. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
3. Absorption inhibitors (i.e. ezetimibe)
4. Fibrates
5. High-dose niacin (≥1 g per day)
6. Bile acid sequestrants (e.g. cholestyramine)
Exclusion Criteria
2. Actively engaged in another dietary intervention or taking a weight-loss supplement
3. SBP ≥190 mm Hg or DBP ≥110 mm Hg (at Visit #1)
4. Low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dl, triglycerides (TG) ≥600 mg/dl, or glucose ≥400 mg/dl (at Visit #1)
5. Evidence of prior diagnosis of severe chronic kidney disease (CKD) defined by electronic health record codes for dialysis, CKD Stage 4 or 5 and/or last estimated glomerular filtration rate (eGFR) ≤30 ml/min/1.732 \[based on Modification of Diet in Renal Disease (MDRD) formula\]
6. Active cancer other than non-melanoma skin cancers (i.e. basal cell carcinoma or squamous cell carcinoma)
7. Diagnosis of celiac disease, ulcerative colitis, or Crohn's disease
8. High risk for alcohol use disorder:
1. ≥21 drinks a week (men)
2. ≥14 drinks a week (women)
9. Women who are pregnant or plan to become pregnant within the next 6 months from the start of the study (Day 0)
10. Food allergies requiring a specialized diet, including allergies to dairy products, eggs, peanuts, tree nuts, soy, gluten-containing wheat and grains, fish, and shellfish
11. Previous visit at TLC for diet counseling
12. Previous use of the Kroger's online shopping platform (Kroger.com or the Kroger app)
13. Participant lives greater than 20 miles from any participating Kroger study store (defined by zip codes)
14. Women, Infants, and Children (WIC) beneficiaries in their household
21 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Kroger Company
UNKNOWN
Children's Hospital Medical Center, Cincinnati
OTHER
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dylan Steen
Director of Clinical Trials and Population Health Research, UC Heart, Lung, and Vascular Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dylan L Steen, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Sarah C Couch, RD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati Medical Center - UC Health
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Steen DL, Helsley RN, Bhatt DL, King EC, Summer SS, Fenchel M, Saelens BE, Eckman MH, Couch SC. Efficacy of supermarket and web-based interventions for improving dietary quality: a randomized, controlled trial. Nat Med. 2022 Dec;28(12):2530-2536. doi: 10.1038/s41591-022-02077-7. Epub 2022 Dec 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20168163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.